Infection prevention

New clinical trial shows 39% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube

A new study has been published on Bactiguard’s endotracheal tube (BIP ETT) that shows a significant reduction of both ventilator-associated pneumonia (VAP) and antibiotic use. This randomized controlled study on 180 intensive care patients was published in the Balcan Medical Journal, in March 2022. The main objective of the study was to evaluate...

The silent pandemic of antimicrobial resistance is louder than ever

Antimicrobial resistance already causes millions of deaths according to the most comprehensive study on the burden of AMR so far, published in The Lancet. It shows that almost 1,3 million deaths were directly attributable to bacterial AMR in 2019 and almost 5 million deaths associated with AMR. This is evidence that the fight against antimicrobial...

More than 50% risk reduction of ventilator associated pneumonia with Bactiguard’s Technology

A new study from Liège, Belgium, shows that the usage of Bactiguard’s infection preventive endotracheal tube reduces ventilator associated pneumonia (VAP) with 53% in intensive care patients. The study VITAL was presented in the beginning of October at the European Society of Intensive Care Medicine Congress (ESICM) where it was selected as one...

Sepsis always starts with an infection – causes at least 11 million deaths globally each year.

Sepsis is the number one preventable cause of death in the world, but very few people know what it is and what the consequences are. Every year, around 49 million people suffers from sepsis and 11 million don’t survive. To raise awareness about how to prevent and identify signs of sepsis, World Sepsis Day takes place every year on September...

Healthcare acquired infections increase the mortality during Covid-treatment

Overuse of antibiotics and superbugs could be worsening the Covid-19 pandemic in India, according to an Indian Council of Medical Research (ICMR) study of 10 hospitals. The study showed that more than half of the Covid-19 patients who get a secondary bacterial or fungal infection die. Covid-19 mortality worldwide is 10 %, the subgroup of patients...

This is how Bactiguard helps prevent infections and save lives

Antibiotic resistance is one of the most acute health risks of our time. The threat is often referred to as "the silent tsunami" and could potentially nullify hundreds of years of medical progress, according to the WHO. To counteract the resistance, we need to prevent infections in healthcare and in our everyday lives - a challenge for which the...

46% of critically ill COVID-19 patients developed HAI according to new study

A recent Italian publication has studied hospital-acquired infections (HAI) in critically ill COVID-19 patients. 774 patients with COVID-19 treated at intensive care unit (ICU) at 8 hospitals in Italy were included. The publication1 shows that 46 % of the critically ill COVID-19 patients developed HAI, of which 38 % were caused by multi-drug...